% Expired Patents = 33.3

CIPO Patents = 4

EPO Patents = 1

Forward Citations = 16

Loading Chart...

5 inventors (with patents filed for the assignee):

Shailendra K Saxena (3 out of 15 patents)

Wojciech J Ardelt (3 out of 12 patents)

Luis Squiquera (2 out of 4 patents)

4. Jamie Sulley (2 out of 4 patents)

5. Thomas W Hodge, Iii (1 out of 1 patent)

6. Thomas W Hodge (4 patents)

7. Thomas Hodge (0 patent)

6 patents: Sort by Forward Citations

1. 10293032 - Methods and pharmaceuticals for treatment of viral infections of the eye (2019-05-21),

2. 9919034 - Methods of treating and prophylactically protecting mammalian patients infected by viruses classified in Baltimore group V (2018-03-20),

3. 9642794 - Antiviral pharmaceutical for topical administration (2017-05-09),

4. 8808690 - Methods of treating infections originating from viruses in the herpesviridae family (2014-08-19),

5. 8663964 - Methods of treating human papillomavirus (2014-03-04),

6. 8518399 - Methods of treating infections originating from viruses in the herpesviridae family (2013-08-27),

Company Overview

Tamir Biotechnology, Inc. is a biopharmaceutical company focused on developing novel cancer therapies. We leverage cutting-edge technology and scientific expertise to discover and advance innovative treatments that target specific cancer pathways. With a commitment to improving patient outcomes, we strive to bring new therapies to market that address unmet medical needs in oncology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#6 in Short Hills, NJ

#1,675 in New Jersey

#44,981 in US

Short Hills, NJ, United States of America

Tamir Biotechnology, Inc.

Forward Citations = 16

5 inventors:

Shailendra K Saxena (3 out of 15 patents)

Wojciech J Ardelt (3 out of 12 patents)

Luis Squiquera (2 out of 4 patents)

4. Jamie Sulley (2 out of 4 patents)

5. Thomas W Hodge, Iii (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tamir Biotechnology, Inc.. Retrieved from https://idiyas.com/company/tamir-biotechnology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]